Health Care: Drugs

Halozyme Therapeutics Inc (HALO: NASDAQ)

$9.23 -0.17 | -1.81%
10/24/16 - 02:21 PM ET
Company Profile
Price and Volume
Recent Price 9.40
52 Week High 18.65
52 Week Low 6.96
Avg. Daily Vol. (Mil) 1.30
Beta (3 year) 1.84
Share Related Items
Mkt Cap (Mil) 1,216.49
Shares Out (Mil) 129.41
Float (Mil) 95.34
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.50
Current Ratio 7.30
LT Debt/ Equity 20.65
Total Debt / Equity 20.98
Valuation Ratios
Price Earnings n.a.
Price/Sales 8.17
Price/Book 122.63
Price/Cash Flow -19.00
Per Share Data
Earnings -0.52
Sales 1.15
Book Value 0.08
Cash Flow -0.50
Business Summary
Halozyme Therapeutics Inc is a biopharmaceutical company. It is engaged in research on human enzymes that alter the extracellular matrix and tumor environment.
General Information
11388 Sorrento Valley Road
San Diego, CA 92121
Industry : Drugs
Sector: Health Care
Employees: 216
CEO: Dr. Helen Torley, MB.Ch.
Short Interest
Current Month (Mil) 21.24
Previous Month (Mil) 22.11
Short Interest Ratio (Days) 14.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -22.60
Return on Investments -31.10
Gross Margin 81.20
EBIT Margin -36.80
Profit Margin -44.90

Portfolios with HALO

Latest HALO Headlines from TheStreet

More Financial News for HALO

Press Releases for HALO

See All Press Releases

Partner Headlines for HALO

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter